Boxer Capital, LLC - Insider Trading & Ownership

Location
12860 El Camino Real, Suite 300, San Diego, CA
Summary
The estimated value of insider holdings of Boxer Capital, LLC is at least $293M dollars as of May 14, 2024. Boxer Capital, LLC is the Other* of Tango Therapeutics, Inc. and owns shares of Tango Therapeutics, Inc. (TNGX) stock worth about $139M. Boxer Capital, LLC is the Other* of Tyra Biosciences, Inc. and owns shares of Tyra Biosciences, Inc. (TYRA) stock worth about $94.2M. Boxer Capital, LLC is the Other* of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $51.6M. Boxer Capital, LLC is the 10%+ Owner of Odonate Therapeutics, Inc. and owns shares of Odonate Therapeutics, Inc. stock worth about $6.54M. Boxer Capital, LLC is the Aaron Davis, the CEO of Boxer Capital, LLC, is a director of Rain Oncology Inc. of Rain Oncology Inc. and owns shares of Rain Oncology Inc. stock worth about $1.39M.
Signature
/s/ Aaron I. Davis, Chief Executive Officer, Boxer Capital, LLC
All Insider Reports
All Insider Reports

Ownership of Boxer Capital, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TNGX Tango Therapeutics, Inc. Other* $139M Oct 13, 2023
TYRA Tyra Biosciences, Inc. Other* $94.2M Feb 6, 2024
ITOS iTeos Therapeutics, Inc. Other* $51.6M May 10, 2024
ODTC Odonate Therapeutics, Inc. 10%+ Owner $6.54M Nov 22, 2021
RAIN Rain Oncology Inc. Aaron Davis, the CEO of Boxer Capital, LLC, is a director of Rain Oncology Inc. $1.39M May 22, 2023
MRTX Mirati Therapeutics, Inc. Other* Jan 23, 2024

Insider Transactions Reported by Boxer Capital, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.